BioEver Co., Ltd agreed to acquire 11.4% stake in Biogenicskorea Co., Ltd from PATI Games Corporation (KOSDAQ:A194510) for KRW 9.5 billion on May 11, 2018. Under the terms, BioEver Co., Ltd will acquire 0.19 million shares of Biogenicskorea Co., Ltd. As per the amendment report on August 8, 2018, The OOZOO Co., Ltd. will acquire 11.4% stake in Biogenicskorea Co., Ltd from PATI Games Corporation for KRW 9.5 billion. The amount of KRW 300 million paid before the signing of this contract and the total contract amount of KRW 2 billion, which has been paid to PATI Games according to the letter of commitment by OOZOO will be converted into the deposit on signing the contract. OOZOO shall transfer the amount of KRW 2.5 billion to the bank account designated by PATI Games on October 11, 2018 as the second payment. And the balance of KRW 4.7 billion will be paid on December 11, 2018. Post-acquisition, PATI Games Corporation will not hold any shares in Biogenicskorea Co., Ltd. The transaction has been resolved by the Board of Directors of PATI Games Corporation on May 11, 2018. The Board of Directors of PATI Games Corporation passed a resolution on the transaction with OOZOO on August 8, 2018. The transaction is expected to be completed on August 11, 2018. The transaction is now expected to complete on December 11, 2018. Lian Accounting Corporation acted as External Rating Institution in a transaction.